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per 100 000 in the general population. Recent stud-
ies in molecular genetics have shown that multiple 
BCC are caused by mutations in the PTCH (Patched) 
gene found on chromosome 9q. Additionally, pa-
tients with Gorlin-Goltz syndrome tend to develop 
more benign skin lesions regrouped under the de-
nominations of basocellular nevi or basaloid follicu-
lar hamartomas.
Observation:
Here we present the case of a 4 year-old boy pre-
senting with an agenesis of corpus callosum at birth 
and who has subsequently developed multiple der-
moid cysts of the face, macrocephalia, congenital 
convergent strabism and an important develop-
mental delay. A genetic cause has been discussed 
and following multiple investigations, a mutation in 
the PTCH gene has been demonstrated, thus con-
firming the diagnosis of Gorlin-Goltz syndrome. The 
patient has subsequently, since 2011, developed 
skin lesions on the whole body. Assuming the diag-
nosis of Gorlin-Goltz syndrome, we suspected the 
occurrence of BCCs. Excisional biopsies performed 
on several body areas showed basaloid tumoral 
processes without all of the classical aspects of BCC 
(absence of palisading or peritumoral retractions). 
We finally diagnosed these lesions as basocellular 
nevi, a histopathological entity of better prognosis 
than classical BCC. The patient has therefore under-
gone superficial excisions of the different lesions 
instead of classical surgical removals of the tumors.
Discussion:
Gorlin-Goltz syndrome is classically associated with 
the rapid and progressive occurrence of multiple 
BCC throughout life, with potential impacts on the 
quality of life and overall survival of the patients. 
Other clinical and histopathological entities such as 
basocellular nevi or basaloid follicular hamartomas 
can also be found in these patients. These lesions 
tend to be less extensive than true BCC and can be 
managed without need for complete surgical exci-
sions especially in young patients.
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We describe a case of a 67-year old woman who 
develops three painful subcutaneous nodules with 
surrounding erythema and a central hemorrhagic 
crust localized on the left wrist and the upper back 
after having spent her holidays in Mexico. Soon af-
ter the first visit at our clinic she was able to extract 
a larva, allowing to diagnose a cutaneous myiasis 
from furuncular subtype.
There is a worldwide distribution of myiasis, but 
with more species and abundance in lower socio-
economic regions of tropical and subtropical re-
gions. With a higher number of returning travelers 
from these regions we are more often confronted 
with tropical infections or parasites implicating 
knowledge about differential diagnosis, diagnostic 
and therapeutic approaches.
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Introduction: We report a case of Mycobacterium 
marinum in Crohn’s patient on adalimumab, who 
was treated with antibiotics without interruption of 
the anti-TNF agent.
Observation: A 44-year-old man who had received 
adalimumab for Crohn’s disease over the previous 
5 years, presented to our clinic with a history of 2 
months asymptomatic lesions on the right arm. He 
developed a progressive inflammatory nodular in-
filtrate on his right wrist followed by the onset of le-
sion over the forearm and arm with a sporotrichoid 
pattern. A non painful swollen right axillary node 
was noted. He owns a home fish tank that he used 
to clean regularly with his right hand. Skin biopsy 
was taken and histology revealed a moderate lym-
pho-histiocytic and granulomatous infiltrate. Even 
with the negative specific coloration, the suspicion 
of M. marinum infection was high, and we decided 
to treat the patient without stopping the anti-TNF. 
An antibiotherapy with rifampicine and clarithro-
mycin was installed. Meanwhile, the infection with 
M. marinum was confirmed by bacterial culture. A 
complete remission was noted after 26 weeks of an-
tibiotherapy, with no relapse at the third month of 
follow-up.
Discussion: The anti-TNF therapy was a revolution 
in the treatment of chronic inflammatory diseases 
since its introduction over the decade. The increased 
risk of opportunistic infections, including atypical 
mycobacterial infections, has been reported with 
the use of anti-TNF. M. marinum is a free-living my-
cobacterium subspecies whose natural habitat is 
water. Exposure to fresh or salt water fish associated 
with injuries can cause M. marinum infection. There 
is no consensus for the therapy, but combination of 
rifampicin with clarithromycin + etambutol seems 
to resolve skin lesions and to induce total remission. 
A discontinuation of anti-TNF is recommended, but 
not mandatory. Among 17 cases of M. marinum 
cutaneous infections reported in the literature, the 
anti-TNF was held while the patients were receiv-
ing the anti-mycobacterial treatment. In 3 cases, an 
anti-TNF was reintroduced once the infection was 
completely treated. In 3 another patients, it was re-
sumed while they were still on antibiotics.
Conclusion: In our case, a Crohn’s disease patient 
was treated and healed from a M. marinum infec-
tion, without interruption of adalimumab therapy. 
This may lead to reconsider the necessity of dis-
continuing anti-TNF agents in the case of a benign 
course of the infectious disease.
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